The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125633611 12563361 1 I 2015 20160706 20160715 20160715 EXP US-ABBVIE-16K-163-1669994-00 ABBVIE 0.00 F Y 0.00000 20160715 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125633611 12563361 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous LOADING DOSE 1057363 125057 160 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
125633611 12563361 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous LOADING DOSE 1057363 125057 80 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
125633611 12563361 3 SS HUMIRA ADALIMUMAB 1 Subcutaneous 1057363 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
125633611 12563361 4 SS HUMIRA ADALIMUMAB 1 Subcutaneous 1057363 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN /wk
125633611 12563361 5 SS NORVASC AMLODIPINE BESYLATE 1 Unknown U UNKNOWN 0 10 MG QD
125633611 12563361 6 SS ATORVASTATIN ATORVASTATIN 1 Unknown Y UNKNOWN 0
125633611 12563361 7 C BENICAR OLMESARTAN MEDOXOMIL 1 0
125633611 12563361 8 C METOPROLOL. METOPROLOL 1 0
125633611 12563361 9 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 0
125633611 12563361 10 C ESTRADIOL. ESTRADIOL 1 0
125633611 12563361 11 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 0
125633611 12563361 12 C POTASSIUM POTASSIUM 1 0
125633611 12563361 13 C MELATONIN MELATONIN 1 0
125633611 12563361 14 C CHARCOAL ACTIVATED CHARCOAL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125633611 12563361 1 Crohn's disease
125633611 12563361 5 Product used for unknown indication
125633611 12563361 6 Blood cholesterol increased
125633611 12563361 7 Hypertension
125633611 12563361 8 Hypertension
125633611 12563361 9 Gastrooesophageal reflux disease
125633611 12563361 10 Hormone replacement therapy
125633611 12563361 11 Insomnia
125633611 12563361 12 Product used for unknown indication
125633611 12563361 13 Insomnia
125633611 12563361 14 Crohn's disease

Outcome of event

Event ID CASEID OUTC COD
125633611 12563361 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125633611 12563361 Arthralgia
125633611 12563361 Blood calcium increased
125633611 12563361 Blood pressure increased
125633611 12563361 Drug ineffective
125633611 12563361 Dyspnoea
125633611 12563361 Goitre
125633611 12563361 Headache
125633611 12563361 Joint swelling
125633611 12563361 Parathyroid gland enlargement
125633611 12563361 Peripheral swelling
125633611 12563361 Tinnitus
125633611 12563361 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125633611 12563361 1 201407 201407 0
125633611 12563361 2 2014 2014 0
125633611 12563361 3 2014 2015 0
125633611 12563361 4 2015 0
125633611 12563361 6 201605 0